The MS Podcast
Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice
Avsnitt

Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice

In this episode we’ll talk more about what hides behind the structures of our brain, in the core of the thalamus. Thalamic atrophy measurements have existed for a long time, but within MS it is quite new to look into the thalamic atrophy, also as a biomarker. Today’s guest, Prof. Dr. Cristina Granziera, will tell us more about how knowledge about thalamic atrophy can be implemented in clinical practice.

GZNO.MS.19.11.0310

Podden och tillhörande omslagsbild på den här sidan tillhör Sanofi Genzyme. Innehållet i podden är skapat av Sanofi Genzyme och inte av, eller tillsammans med, Poddtoppen.